Xeris Retires All 2028 Convertible Notes via Exchange and Conversion, Issuing 8.6M Shares

summarizeSummary

Xeris retired all remaining 2028 convertible notes through an exchange and conversion, issuing 8.6 million shares and paying $23 million cash. The move eliminates the convertible overhang entirely.

check_boxKey Events · Financing and Capital Events · XERS

• 2028 Notes Fully Retired

  Xeris completed the exchange of $23M in 2028 convertible notes for ~5.0M shares and $23M cash, and a separate holder converted $10.5M into ~3.6M shares. No 2028 Notes remain outstanding.

• Dilution Impact

  Total shares issued: ~8.6M, representing approximately 5% dilution based on ~172M shares outstanding. The cash portion was funded with on-hand liquidity.

• Capital Structure Simplification

  Retiring the convertible notes removes a potential overhang and future dilution risk, simplifying the balance sheet as the company transitions to sustained profitability.

• Follow-Through on Prior Announcement

  The exchange was initially disclosed on June 11, 2026, with an estimated 4.6M shares; final count increased to 5.0M. The additional conversion was not previously announced.

auto_awesomeAnalysis · XERS · Life Sciences

Xeris completed the previously announced exchange of $23M in 2028 convertible notes for ~5.0M shares and $23M cash, and a separate holder converted $10.5M into ~3.6M shares. The combined 8.6M shares represent roughly 5% dilution but eliminate the entire 2028 note overhang — removing a potential source of future dilution and simplifying the capital structure. The cash portion was funded with on-hand liquidity, preserving balance sheet strength. This follows a strong Q1 where the company achieved net income and positive operating cash flow, making the debt retirement a deleveraging milestone.